Cargando…
Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction
Serine hydroxymethyltransferase (SHMT) is an enzyme that catalyzes the reaction that converts serine to glycine. It plays an important role in one-carbon metabolism. Recently, SHMT has been shown to be associated with various diseases. Therefore, SHMT has attracted attention as a biomarker and drug...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382819/ https://www.ncbi.nlm.nih.gov/pubmed/30787298 http://dx.doi.org/10.1038/s41467-019-08833-7 |
_version_ | 1783396725838315520 |
---|---|
author | Nonaka, Hiroshi Nakanishi, Yuki Kuno, Satoshi Ota, Tomoki Mochidome, Kentaro Saito, Yutaro Sugihara, Fuminori Takakusagi, Yoichi Aoki, Ichio Nagatoishi, Satoru Tsumoto, Kouhei Sando, Shinsuke |
author_facet | Nonaka, Hiroshi Nakanishi, Yuki Kuno, Satoshi Ota, Tomoki Mochidome, Kentaro Saito, Yutaro Sugihara, Fuminori Takakusagi, Yoichi Aoki, Ichio Nagatoishi, Satoru Tsumoto, Kouhei Sando, Shinsuke |
author_sort | Nonaka, Hiroshi |
collection | PubMed |
description | Serine hydroxymethyltransferase (SHMT) is an enzyme that catalyzes the reaction that converts serine to glycine. It plays an important role in one-carbon metabolism. Recently, SHMT has been shown to be associated with various diseases. Therefore, SHMT has attracted attention as a biomarker and drug target. However, the development of molecular probes responsive to SHMT has not yet been realized. This is because SHMT catalyzes an essential yet simple reaction; thus, the substrates that can be accepted into the active site of SHMT are limited. Here, we focus on the SHMT-catalyzed retro-aldol reaction rather than the canonical serine–glycine conversion and succeed in developing fluorescent and (19)F NMR molecular probes. Taking advantage of the facile and direct detection of SHMT, the developed fluorescent probe is used in the high-throughput screening for human SHMT inhibitors, and two hit compounds are obtained. |
format | Online Article Text |
id | pubmed-6382819 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-63828192019-02-22 Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction Nonaka, Hiroshi Nakanishi, Yuki Kuno, Satoshi Ota, Tomoki Mochidome, Kentaro Saito, Yutaro Sugihara, Fuminori Takakusagi, Yoichi Aoki, Ichio Nagatoishi, Satoru Tsumoto, Kouhei Sando, Shinsuke Nat Commun Article Serine hydroxymethyltransferase (SHMT) is an enzyme that catalyzes the reaction that converts serine to glycine. It plays an important role in one-carbon metabolism. Recently, SHMT has been shown to be associated with various diseases. Therefore, SHMT has attracted attention as a biomarker and drug target. However, the development of molecular probes responsive to SHMT has not yet been realized. This is because SHMT catalyzes an essential yet simple reaction; thus, the substrates that can be accepted into the active site of SHMT are limited. Here, we focus on the SHMT-catalyzed retro-aldol reaction rather than the canonical serine–glycine conversion and succeed in developing fluorescent and (19)F NMR molecular probes. Taking advantage of the facile and direct detection of SHMT, the developed fluorescent probe is used in the high-throughput screening for human SHMT inhibitors, and two hit compounds are obtained. Nature Publishing Group UK 2019-02-20 /pmc/articles/PMC6382819/ /pubmed/30787298 http://dx.doi.org/10.1038/s41467-019-08833-7 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Nonaka, Hiroshi Nakanishi, Yuki Kuno, Satoshi Ota, Tomoki Mochidome, Kentaro Saito, Yutaro Sugihara, Fuminori Takakusagi, Yoichi Aoki, Ichio Nagatoishi, Satoru Tsumoto, Kouhei Sando, Shinsuke Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction |
title | Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction |
title_full | Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction |
title_fullStr | Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction |
title_full_unstemmed | Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction |
title_short | Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction |
title_sort | design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382819/ https://www.ncbi.nlm.nih.gov/pubmed/30787298 http://dx.doi.org/10.1038/s41467-019-08833-7 |
work_keys_str_mv | AT nonakahiroshi designstrategyforserinehydroxymethyltransferaseprobesbasedonretroaldoltypereaction AT nakanishiyuki designstrategyforserinehydroxymethyltransferaseprobesbasedonretroaldoltypereaction AT kunosatoshi designstrategyforserinehydroxymethyltransferaseprobesbasedonretroaldoltypereaction AT otatomoki designstrategyforserinehydroxymethyltransferaseprobesbasedonretroaldoltypereaction AT mochidomekentaro designstrategyforserinehydroxymethyltransferaseprobesbasedonretroaldoltypereaction AT saitoyutaro designstrategyforserinehydroxymethyltransferaseprobesbasedonretroaldoltypereaction AT sugiharafuminori designstrategyforserinehydroxymethyltransferaseprobesbasedonretroaldoltypereaction AT takakusagiyoichi designstrategyforserinehydroxymethyltransferaseprobesbasedonretroaldoltypereaction AT aokiichio designstrategyforserinehydroxymethyltransferaseprobesbasedonretroaldoltypereaction AT nagatoishisatoru designstrategyforserinehydroxymethyltransferaseprobesbasedonretroaldoltypereaction AT tsumotokouhei designstrategyforserinehydroxymethyltransferaseprobesbasedonretroaldoltypereaction AT sandoshinsuke designstrategyforserinehydroxymethyltransferaseprobesbasedonretroaldoltypereaction |